Duration of Effect of Alipogene Tiparvovec Treatment, Which Was Administered in Other Studies

Clinical trial NCT01447901 · TERMINATED

Trial details

NCT number: NCT01447901
Sponsor: Amsterdam Molecular Therapeutics
Status: TERMINATED
Study type: OBSERVATIONAL

Hyperlipoproteinemia Type I

Start date: 2011-09-01
Primary completion: 2012-09-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.